Eye Other
Primary Site | Histology |
---|---|
C691-C694, C696, C698-C699 | 8000-8700, 9700-9701 |
C691-C692, C695-C696, C698-C699 | 8720-8790 |
Notes
8000-8700, 9700-9701 (C691-C694, C696, C698-C699 ) 8720-8790 (C691-C692, C695-C696, C698-C699) C691 Cornea, NOS C692 Retina C693 Choroid C694 Ciliary Body C695 Lacrimal Gland C696 Orbit, NOS C698 Overlapping lesion of eye and adnexa C699 Eye, NOS **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx **Note 2:** See the following schemas for the listed histologies * C691-C694, C696, C698-C699 (8710-8714, 8800-8921, 8932-8934, 8940-8990, 9000-9016, 9030-9137, 9141-9175, 9181-9230, 9240-9509, 9520-9582): *Orbital Sarcoma* * C693, C694 (8720-8790): *Melanoma Uvea* * C695 (8000-8700, 8941, 8980, 8982, 9700-9701): *Lacrimal Gland* and *Lacrimal Sac* * C695 (8710-8714, 8800-8921, 8932-8934, 8940, 8950-8975, 8981, 8983-8990, 9000-9016, 9030-9137, 9141-9175, 9181-9230, 9240-9509, 9520-9582): *Orbital Sarcoma* * 8930-8931, 8991, 9020, 9180, 9231: *Soft Tissue Other* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* * 9510-9514: *Retinoblastoma* **Note 3:** Summary Stage is the only applicable staging system for this site/histology/schema.Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
Tumor Size Clinical | <BLANK> | No | NAACCR #752 | None | |
Tumor Size Pathological | <BLANK> | No | NAACCR #754 | None | |
Tumor Size Summary | 999 | No | NAACCR #756 | None | |
Regional Nodes Positive | 99 | No | NAACCR #820 | None | |
Regional Nodes Examined | 99 | No | NAACCR #830 | None | |
LVI | 8 | No | NAACCR #1182 | None | |
EOD Primary Tumor | 999 | Yes | NAACCR #772 | None | |
EOD Regional Nodes | 999 | Yes | NAACCR #774 | None | |
EOD Mets | 00 | Yes | NAACCR #776 | None | |
SS2018 | <BLANK> | No | NAACCR #764 | None | |
Grade Clinical | 9 | No | NAACCR #3843 | CCCR/Canada COC NPCR SEER |
SSDI |
Grade Pathological | 9 | No | NAACCR #3844 | CCCR/Canada COC NPCR SEER |
SSDI |
Grade Post Therapy | <BLANK> | No | NAACCR #3845 | CCCR/Canada COC NPCR SEER |
SSDI |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Schema ID | 00718 |
NAACCR #3800
None |
None | |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Summary Stage 2018 | 9 |
NAACCR #762
None |
None |